Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression

Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. In the absence of targeted therapies, it invariably progresses to advanced chronic kidney disease. To date, the only approved treatment is tolvaptan, a vasopressin V2 receptor antagonist that has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiroga, Borja, Torra, Roser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658114/
https://www.ncbi.nlm.nih.gov/pubmed/36364911
http://dx.doi.org/10.3390/nu14214651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658114/
https://www.ncbi.nlm.nih.gov/pubmed/36364911
http://dx.doi.org/10.3390/nu14214651

Ejemplares similares